Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors
Clinical trial NCT05749627 · RECRUITING
Trial details
- NCT number
- NCT05749627
- Sponsor
- The First Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.